Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Combat Meth Enhancement looks likely

This article was originally published in The Tan Sheet

Executive Summary

Congressional staff expect the Combat Methamphetamine Enhancement Act to pass after the Senate and House agree to "minor technical corrections" in the legislation that requires retailers to comply with provisions of the Combat Methamphetamine Epidemic Act of 2006. Minor changes in the House bill passed Sept. 22 include tweaking phrasing, statutory citations, adding a statement to comply with the PAYGO Act and replacing 2009 with 2010 in the title. A Feinstein staffer said Senate members likely will approve the House version the week of Sept. 27. The bill requires retailers to self-certify compliance with Drug Enforcement Administration regulations concerning Combat Met Act retail sales provisions. It sets $5,000 penalties for noncompliance and prohibits distributors from delivering pseuodephedrine-containing OTCs to noncompliant stores. The Consumer Healthcare Products Association and the National Association of Chain Drugstores support the measure, which enhances regulations limiting sales of PSE without creating new restrictions on consumer access to the drugs (1"The Tan Sheet" Aug. 2, 2010, In Brief)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS104532

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel